Funding, launches and regulatory moves across the neurotech startup map.
Subscribed. Check your inbox to confirm.
•
Neurofounders Insights
$ Funding -
Seed
MODALITY
EEG
FORM FACTOR
Earbud/headphone
INTERFACE DEPTH
Non-invasive
INDICATION
Sleep
TARGET USER
Mixed
REGULATORY STAGE
FDA cleared (510k)
NAOX Technologies is positioned around in-ear EEG as a continuous monitoring modality that could bridge clinical and home use. Its discreet form factor is compelling, though it must still prove that ear-EEG delivers sufficient signal quality for meaningful medical applications.
Naox Technologies received ethics-board approval to begin MONIEAR, a study of long-term in-ear EEG monitoring in focal epilepsy. It will compare Naox's in-ear EEG with scalp EEG in clinic before following patients at home for several months.